BIOFTALMIK S L has a total of 17 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, measurement and biotechnology are RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MED, TOUMAZOU CHRISTOFER and ERICSON DANIEL G.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Implantable devices | |
#4 | Syringes | |
#5 | Object sterilising | |
#6 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Suarez Cortes Tatiana | 13 |
#2 | Acera Osa Arantxa | 10 |
#3 | Soria Esponera Javier | 10 |
#4 | Gonzalez Fernandez Nerea | 6 |
#5 | Garcia Jimenez Iker | 5 |
#6 | Careaga Goicoechea Jon | 3 |
#7 | Igarza Javier | 3 |
#8 | Vega Chaparro Sandra Clarissa | 3 |
#9 | Rodriguez Aguirreche Ignacio | 2 |
#10 | Corcóstegui Crespo Iñigo | 2 |
Publication | Filing date | Title |
---|---|---|
EP2810675A1 | Injector for intraocular injection | |
EP2556842A1 | Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof | |
EP2522368A1 | Microparticles for intraocular tissue marking | |
EP2431744A1 | In vitro diagnostic method for infant eye allergy | |
EP2428583A1 | Method of prognosis for the success of filtering surgery and for determining the progress of cicatrization | |
EP2418491A1 | Method for the diagnosis of dry eye and blepharitis | |
EP2309003A1 | Method for the diagnosis of limbal stem cell deficiency |